PHARMACEUTICAL COMPOSITION COMPRISING A SELECTIVE PHOSPHODIESTERASE ENZYME INHIBITOR IN ORAL GEL FORM

摘要

The invention concerns a novel stable, semi-solid composition for oral administration comprising at least one selective phosphodiesterase enzyme inhibitor and/or at least one pharmaceutically acceptable excipient. Once administered orally, the composition maintains sustained release, doubling the length of time for which the active ingredient remains in the organism and prolonging the therapeutic effect of the selective phosphodiesterase enzyme inhibitor. The semi-solid composition can be used for selective phosphodiesterase enzyme inhibition, for example, in a non-restrictive manner, for controlling or treating erectile dysfunction, with a therapeutic effect lasting for up to eight hours.